EverestIMS Technologies
Price Band
₹85
Lot Size
3,200 Shares
Issue Size
₹48.46 Cr
Fresh Issue
₹39.05 Cr
OFS
₹9.41 Cr
Registrar
AI Sentiment Score
Listing Price
₹126.00
vs Issue: ₹85 (+48.24%)
📅 IPO Timeline
✓
Open
Sep 29, 2026
✓
Close
Oct 5, 2026
✓
Allotment
Oct 6, 2026
✓
Refund
Oct 7, 2026
✓
Demat
Oct 7, 2026
✓
Listing
Oct 8, 2026
📈 Grey Market Premium (GMP) Trendline
Daily consensus GMP movement (₹) recorded across market sources
✨ AI Analysis & Prediction
🔒 Final Reconciled Estimate
Locked post-listing with actual debut performance
EverestIMS Technologies presents an exceptionally strong SME public offering backed by massive institutional and retail demand, robust software SaaS revenue metrics, and proprietary AIOps platforms. With a stellar weighted institutional demand score and solid financial fundamentals, the issue offers high compounding potential for long-term investors despite minor SME liquidity constraints.
💪 Strengths
- Proprietary enterprise software and AIOps platforms ('Infraon Infinity') ensuring high customer stickiness.
- Exceptional financial returns with ROCE of 36.15% and ROE of 24.33% in FY26.
- Strong operating margins with an EBITDA margin of 35.41% and PAT margin of 19.93%.
- Overwhelming subscription demand across QIB (148.63x) and NII (548.61x) categories.
⚠️ Weaknesses
- Heavy reliance on IT, telecom, and BFSI industry verticals for major revenue generation.
- SME exchange listing constraints leading to relatively lower secondary market liquidity.
- Modest absolute scale compared to mainboard enterprise software giants.
🚀 Opportunities
- Expansion into global markets leveraging the US subsidiary (Infraon Corp.).
- Deployment of the AI Innovation and Experience Laboratory to capture advanced AIOps demand.
- Accelerating enterprise digital transformation and Industry 4.0 automation trends worldwide.
🛡️ Threats
- Intense competition in the global IT Operations and Service Management (ITOSM) market.
- Rapid technological obsolescence requiring continuous R&D expenditure.
- Potential macroeconomic headwinds impacting enterprise IT budgets and software spending.
🎯 Objectives of the IPO
| Requirement / Purpose | Amount (₹ Cr) |
|---|---|
| Purchase of IT hardware for setting up of Artificial Intelligence (AI) Innovation and Experience Laboratory | ₹5.66 |
| Working Capital Requirement | ₹24.00 |
| General Corporate Purposes | ₹18.80 |
📊 Financial Overview & Growth Trajectory
Multi-year operational scale & net profitability trajectory
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | Rs 45.00 Cr | Rs 57.00 Cr | Rs 65.00 Cr |
| Net Profit / PAT (₹ Cr) | Rs 11.00 Cr | Rs 14.00 Cr | Rs 13.00 Cr |
| EBITDA / Op. Profit (₹ Cr) | Rs 17.00 Cr | Rs 21.00 Cr | Rs 23.00 Cr |
| Borrowings (₹ Cr) | Rs 0.00 Cr | Rs 0.00 Cr | Rs 0.00 Cr |
| Total Assets (₹ Cr) | Rs 50.00 Cr | Rs 68.00 Cr | Rs 90.00 Cr |
| ROCE % | 56.00% | 46.00% | 33.00% |
📋 Live Subscription Status
QIB
148.63x
NII
548.61x
Retail
268.29x
Total
294.22x
🎯 Retail Allotment Probability
0.4% Odds
1 in 268.3 chance (~0.4% probability per PAN)
SEBI Rule: Under SEBI lottery allotment rules, applying for multiple lots under Retail does NOT increase your lottery odds. All valid retail applicants have identical 1-lot odds per PAN.
Updated: Oct 8, 2026 8:05 AM
💼 Issue Structure & Reservation Quota
Capital Structure
₹48.5 Cr
Issue Size
Fresh (80.6%)
OFS (19.4%)
Reservation Quota
100%
Allocation
NII (50%)
Retail (50%)
QIB
0.00%
Retail
50.00%
NII
50.00%
📈 Shareholding & Anchor Lock-In
🔗 Important Links & Lead Managers
- Registrar WebsiteVisit →
- Download DRHP ProspectusDownload PDF 📥
- Download RHP ProspectusDownload PDF 📥
Lead Managers / Merchant Bankers
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.